Chemical genomic profiling to identify intracellular targets of a multiplex kinase inhibitor.
The identification of the kinase or kinases targeted by protein kinase inhibitors is a critical challenge in validating their use as therapeutic agents or molecular probes. Here, to address this problem, we describe a chemical genomics strategy that uses a direct comparison between microarray transcriptional signatures elicited by an inhibitor of unknown specificity and those elicited by highly specific pharmacological inhibition of engineered candidate kinase targets. By using this approach, we have identified two cyclin-dependent kinases, Cdk1 and Pho85, as the targets of the inhibitor GW400426 in Saccharomyces cerevisiae. We demonstrate that simultaneous inhibition of Cdk1 and Pho85, and not inhibition of either kinase alone, by GW400426 controls the expression of specific transcripts involved in polarized cell growth, thus revealing a cellular process that is uniquely sensitive to the multiplex inhibition of these two kinases. Our results suggest that the cellular responses induced by multiplex protein kinase inhibitors may be an emergent property that cannot be understood fully by considering only the sum of individual inhibitor-kinase interactions.
Kung
Charles
C
Computational, Analytical, and Structural Sciences, GlaxoSmithKline, 5 Moore Drive, Research Triangle Park, NC 27709, USA.
Kenski
Denise M
DM
Dickerson
Scott H
SH
Howson
Russell W
RW
Kuyper
Lee F
LF
Madhani
Hiten D
HD
Shokat
Kevan M
KM
D016203:CDC2 Protein Kinase / Q000037:antagonists & inhibitors*; D018844:Cyclin-Dependent Kinases / Q000037:antagonists & inhibitors*; D020869:Gene Expression Profiling; D023281:Genomics; D020411:Oligonucleotide Array Sequence Analysis; D047428:Protein Kinase Inhibitors / Q000494:pharmacology*; D029701:Saccharomyces cerevisiae Proteins / Q000037:antagonists & inhibitors*
D047428:Protein Kinase Inhibitors; D029701:Saccharomyces cerevisiae Proteins; D016203:CDC2 Protein Kinase; D018844:Cyclin-Dependent Kinases; C058605:PHO85 protein, S cerevisiae
Chem Biol. 2000 Jun;7(6):411-22
10873834
Nature. 2000 Sep 21;407(6802):395-401
11014197
Mol Biol Cell. 2000 Dec;11(12):4241-57
11102521
Biochem J. 2000 Oct 1;351(Pt 1):95-105
10998351
J Mol Biol. 2001 Mar 9;306(5):997-1010
11237614
J Mol Microbiol Biotechnol. 2001 Apr;3(2):207-14
11321575
Nature. 2001 Jun 28;411(6841):1068-73
11429609
Cell. 2001 Sep 21;106(6):697-708
11572776
Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12578-83
11675494
J Med Chem. 2001 Dec 6;44(25):4339-58
11728181
Mol Cell Biol. 2002 Jul;22(14):5076-88
12077337
Nat Rev Drug Discov. 2002 Apr;1(4):309-15
12120282
J Biol Chem. 2002 Sep 6;277(36):33482-9
12084729
Oncogene. 2002 Sep 12;21(41):6255-63
12214266
Nat Biotechnol. 2004 Jan;22(1):62-9
14661025
Cell. 2004 Jan 9;116(1):121-37
14718172
Annu Rev Immunol. 2004;22:247-306
15032571
PLoS Biol. 2003 Nov;1(2):E28
14624238
Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4525-30
15070751
Cancer Res. 2004 May 1;64(9):3276-80
15126370
Nat Med. 2004 Jun;10(6):643-8
15122251
Adv Cancer Res. 2004;91:1-30
15327887
Science. 1994 Nov 25;266(5189):1388-91
7973730
Science. 1996 Jan 12;271(5246):209-12
8539622
Science. 1997 Oct 24;278(5338):680-6
9381177
Science. 1998 Jul 24;281(5376):533-8
9677190
Nat Med. 1998 Nov;4(11):1293-301
9809554
Microbiol Mol Biol Rev. 1998 Dec;62(4):1191-243
9841670
Mol Biol Cell. 1998 Dec;9(12):3273-97
9843569
Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14863-8
9843981
Proc Natl Acad Sci U S A. 2004 Dec 14;101(50):17456-61
15505216